Antibodies News and Research

RSS

Adaptive immune responses in adults of various ages receiving 2 doses of the BNT162b2 mRNA vaccine

Researchers assessed the correlation between immunosenescence and poor COVID-19 vaccination outcomes in older adults.

21 Oct 2022

Analgesic use after COVID-19 vaccination does not negatively affect antibody responses

In a recent study posted to the medRxiv* preprint server, University of Arizona researchers assessed the relationship between antibody responses and analgesic usage after coronavirus disease 2019 (COVID-19) vaccination.

20 Oct 2022

Multiomics analysis identifies immunobiomarkers for COVID-19 severity in outpatients

In a recent study published in the journal eLife, researchers showed the utility of machine-learning models in identifying early immune signatures, which could reliably predict clinical and immunological outcomes in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-infected outpatients.

20 Oct 2022

Scientists map structure of the hepatitis C virus E1E2 glycoprotein complex

A team led by scientists at Scripps Research and the University of Amsterdam has achieved an important goal in virology: mapping, at high resolution, critical proteins that stud the surface of the Hepatitis C virus (HCV) and enable it to enter host cells.

20 Oct 2022

Three-dose course of the hepatitis B vaccine fully protects adults living with HIV

A three-dose course of the hepatitis B vaccine HEPLISAV-B fully protected adults living with HIV who had never been vaccinated against or infected with the hepatitis B virus (HBV), according to study findings presented today at the IDWeek conference in Washington, D.C.

20 Oct 2022

Breakthrough infection risk and immune responses to vaccines associated with human leukocyte antigen alleles

Researchers from the U.K. used data from clinical trials of the Oxford-AstraZeneca COVID-19 vaccine ChAdOx1 nCoV-19 to understand the genetic factors contributing to the individual variations in the antibody responses to the vaccine.

20 Oct 2022

Impaired SARS-CoV-2 neutralization after booster vaccination in the elderly

A recent study investigates poorer vaccine responses observed in the elderly following receipt of a COVID-19 booster vaccination dose.

19 Oct 2022

Study provides unique picture of blood sugar dynamics and autoimmunity in early childhood

When and why does type 1 diabetes manifest in children? For the first time, researchers conducted a long-term study on infants and young children with increased genetic risk of type 1 diabetes.

19 Oct 2022

SARS-CoV-2 virus alters the composition of breast milk, research shows

A research team from the University of Huelva in collaboration with the MilkCORONA initiative has demonstrated that the SARS-CoV-2 virus alters the composition of breast milk.

19 Oct 2022

Antibodies can prevent surface proteins of bacteria from entering host cells

Using bacteria of the Bartonella henselae species, researchers from Goethe University, Frankfurt University Hospital, the Paul Ehrlich Federal Institute for Vaccines and Biomedicines in Langen, and the University of Oslo demonstrated for the first time that antibodies can prevent certain surface proteins of bacterial pathogens from entering host cells.

19 Oct 2022

Pathophysiological mechanisms of COVID-19-related endothelial dysfunction and potential therapies

Researchers discussed the pathophysiological mechanisms of endothelial dysfunction associated with severe coronavirus disease 2019 (COVID-19) and commented on the potential therapeutic strategies to treat endothelial damage and coagulopathy related to COVID-19.

19 Oct 2022

Rapid and robust pipeline for developing mRNA vaccines for future SARS-CoV-2 variants

A recent study under review at the journal Scientific Reports and currently available on the Research Square* preprint server reported the development of a robust pipeline for fabricating an mRNA vaccine portfolio to combat current and future coronavirus outbreaks, other infectious diseases, and cancer.

19 Oct 2022

Study reveals high level of hybrid immunity in general Swiss population

A recent study covering the general Swiss population has evaluated the development of hybrid immunity during the pandemic wave dominated by the omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

18 Oct 2022

Adaptation-proof SARS-CoV-2 vaccine design is one step closer to reality

A vaccine design approach that could protect against new variants of SARS-CoV-2, the virus that causes COVID-19, but also potentially protects against other coronaviruses is one step closer to reality as a result of Penn State College of Medicine research.

18 Oct 2022

Antibodies News and Research

Adaptive immune responses in adults of various ages receiving 2 doses of the BNT162b2 mRNA vaccine

Analgesic use after COVID-19 vaccination does not negatively affect antibody responses

Multiomics analysis identifies immunobiomarkers for COVID-19 severity in outpatients

Scientists map structure of the hepatitis C virus E1E2 glycoprotein complex

Three-dose course of the hepatitis B vaccine fully protects adults living with HIV

Breakthrough infection risk and immune responses to vaccines associated with human leukocyte antigen alleles

Impaired SARS-CoV-2 neutralization after booster vaccination in the elderly

Study provides unique picture of blood sugar dynamics and autoimmunity in early childhood

SARS-CoV-2 virus alters the composition of breast milk, research shows

Antibodies can prevent surface proteins of bacteria from entering host cells

Pathophysiological mechanisms of COVID-19-related endothelial dysfunction and potential therapies

Rapid and robust pipeline for developing mRNA vaccines for future SARS-CoV-2 variants

Study reveals high level of hybrid immunity in general Swiss population

Adaptation-proof SARS-CoV-2 vaccine design is one step closer to reality

Scientists develop a pseudovirus system to deep mutational scan the full SARS-CoV-2 spike

SARS-CoV-2 placentitis may cause placental destruction and stillbirth in women not vaccinated for COVID-19

New research finds microclotting and inflammatory molecule abnormalities in long-COVID

Unc5-GPC3 complex modulates the migration of neurons and brain-derived cancer cells

What are the predictors of new-onset diabetes in hospitalized COVID-19 patients?

What is the function of micronutrients in COVID-19 recovery?

A new way of characterising biomolecules eBook

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Automating research - solutions and best practices

Latest Life Science News